Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
about
Response gene to complement 32, a novel hypoxia-regulated angiogenic inhibitorHuman alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.Downregulation of VEGF-D expression by interleukin-1beta in cardiac microvascular endothelial cells is mediated by MAPKs and PKCalpha/beta1Photodynamic therapy: combined modality approaches targeting the tumor microenvironment.Time course analysis of RNA stability in human placenta.NFAT and CREB regulate Kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2)Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes.Bioreducible polymers for therapeutic gene deliveryEffects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on ischemic myocardium.Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.Effects of gintonin on the proliferation, migration, and tube formation of human umbilical-vein endothelial cells: involvement of lysophosphatidic-acid receptors and vascular-endothelial-growth-factor signaling.Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on myocardial function and perfusionThe endothelium-dependent effect of RTEF-1 in pressure overload cardiac hypertrophy: role of VEGF-BInfection of human endothelial cells with spotted Fever group rickettsiae stimulates cyclooxygenase 2 expression and release of vasoactive prostaglandinsRegulation of intracellular cyclooxygenase levels by gene transcription and protein degradationRegulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis.Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells.Vascular endothelial growth factor promotes the expression of cyclooxygenase 2 and matrix metalloproteinases in Lewis lung carcinoma cellsCardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery.Bone-marrow-derived stem cells--our key to longevity?Mechanisms of endothelial dysfunction in obstructive sleep apnea.Cyclooxygenase-2 in cancer and angiogenesis.Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands.Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen.Role of A20 in cIAP-2 protection against tumor necrosis factor α (TNF-α)-mediated apoptosis in endothelial cells.Hypoxia-regulated angiogenic inhibitors.Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea.Proton-sensing G protein-coupled receptor mobilizes calcium in human synovial cells.The role of cyclooxygenase-2, interleukin-1β and fibroblast growth factor-2 in the activation of matrix metalloproteinase-1 in sheared-chondrocytes and articular cartilage.Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases.Airway responses to methacholine and exercise at high altitude in healthy lowlanders.Cardioprotective effect of 'methylamine irisolidone', a new compound, in hypoxia/reoxygenation injury in cultured rat cardiac myocytes.Cold induces reactive oxygen species production and activation of the NF-kappa B response in endothelial cells and inflammation in vivo.Chronic hypoxia inhibits contraction of fetal arteries by increased endothelium-derived nitric oxide and prostaglandin synthesis.Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation.Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro.Evidence that very small embryonic-like stem cells are mobilized into peripheral blood.
P2860
Q24320745-CBBD0E5A-E02A-4475-9C49-5D1FB978EF5FQ28271413-2A83057E-4E0E-4342-9041-19E0C21BC531Q28572022-273BBDA0-C9D9-4014-A119-90666BB55E44Q33239559-555F806A-E066-4638-BEDF-9623D152BC94Q33417868-34A14075-04EB-41D2-A87B-1B3A1605AFA6Q33718186-6853A2D5-E329-4C44-AE02-8DB923704DDFQ33867982-A8590193-C924-4062-AA53-2FAD91CD7E85Q33978922-21A63C58-ED8C-4A91-A59D-29679D2AAB07Q34079568-0D159497-3C3F-414F-999A-6FE2164766EDQ34209497-7B8D3356-D711-4CB5-A5DA-57A576CCD706Q34359790-12290CA8-F33C-46A1-A78C-1A0C8AC47708Q34542721-125F4F68-CAE7-463B-8AFD-11EB360E37ABQ34798660-560FDF1D-C2DD-4FC9-BB4A-7EB0C8BC0048Q34808450-DB4040EA-4B8D-49C5-B1D5-F45B9455A989Q35073759-7AD9FAA5-980D-49DF-9CFF-CAF1E98571A2Q35660728-22A8EA4A-C164-4CF3-BB35-8DCE9A35BA09Q35925032-90E7293A-501E-42AD-A625-8112B3A0FDE1Q36016357-A1ED2451-EAAD-4542-BC13-F1F2F72F3AE0Q36386639-EB1A16B0-2B9B-45E4-A5AA-BB8A236C40C2Q36439704-28515D49-95C8-492E-9741-73CFD2B42D95Q36928955-9ECBA2A6-E3B9-4D10-ACA1-1C084487CE43Q36999500-8558A8FC-AF43-4D3A-AA50-D2A6E45CE4CEQ37145667-3E4341F7-3FEF-4977-8C69-36AAFD39A6EBQ37174279-569419C4-C276-4B49-AB14-78344BCC9124Q37215586-96961C2A-8B56-4564-8444-3095FCECC235Q37228936-CABDB7E0-9FF3-4CCA-A440-2F15787A1B67Q37380604-8E4D7D94-0D4A-4A61-BF08-697B2D47A751Q37683997-F9A0C32D-F692-4A8B-AE9B-7E892C9A8040Q37743975-1886519B-717B-4EA1-95BC-338FDF28B415Q37863567-D19E5C9D-CF04-4B63-BB0E-6FED443E161BQ40435435-025AB5AA-6A36-42B9-AB78-D80A909749B1Q40881507-BF4549C4-696F-40A0-BA3E-A648DFA46DB1Q41625930-287D3FC4-F931-45F7-A915-94F4EAA51382Q43235354-18BDB90A-7592-4936-A0FD-0D787D830C11Q43288286-EC7B58B5-1918-4EA0-A1AB-32DF349DFE0DQ43510533-4EE0A9DB-7D8F-4770-84FB-69044127DBF8Q45176122-BA7E7CDA-A970-4774-B5C0-13F77DE30390Q46074966-4FAC4A64-2839-4026-A9FD-BB8CFEF6E0B5Q46562009-5F28391F-5A3C-4068-ADFA-B18BDEC1473FQ46568186-0DB2C3C4-AB4C-4CF2-BD8C-1224F694FCAA
P2860
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
description
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Dezember 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/12/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/12/01)
@nl
наукова стаття, опублікована в грудні 2003
@uk
مقالة علمية (نشرت في ديسمبر 2003)
@ar
name
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
@ast
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
@en
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
@nl
type
label
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
@ast
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
@en
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
@nl
prefLabel
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
@ast
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
@en
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
@nl
P2093
P2860
P1476
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
@en
P2093
Arjuna P. Mannam
Christopher Chen
Frank W. Sellke
Jiaping Wu
Jue-Lon Shie
Roger J. Laham
Simona Kirbis
P2860
P304
H2420–2429
P356
10.1152/AJPHEART.00187.2003
P577
2003-12-01T00:00:00Z